← Back to Search

Health Services Research for Cancer

N/A

Recruiting

Led By Vida Henderson

Research Sponsored by Fred Hutchinson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Are 18 years of age or older

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at post-intervention (up to 15 minutes)

Awards & highlights

Study Summary

This trial aims to address the issue of under-representation of racial/ethnic minority groups in cancer clinical trials, particularly among Black patients. Black patients are less likely to participate in clinical trials despite facing higher

Who is the study for?

This trial is for Black individuals who are currently or have been diagnosed with cancer. It aims to address the under-representation of racial/ethnic minority groups in clinical trials by using a culturally tailored decision aid.Check my eligibility

What is being tested?

The study tests whether a specially designed video and survey can help reduce medical mistrust, increase knowledge about clinical trials, and improve confidence in making decisions among Black cancer patients.See study design

What are the potential side effects?

Since this trial involves educational materials rather than medical treatments, there are no direct physical side effects. Participants may experience emotional responses to the content.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at post-intervention (up to 15 minutes)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at post-intervention (up to 15 minutes)

This trial's timeline: 3 weeks for screening, Varies for treatment, and at post-intervention (up to 15 minutes) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability of the intervention

Change in Clinical Trial Participation Decision-Making Self-Efficacy from Baseline to Post-Intervention: 11-item Decision Self-Efficacy Scale

Change in Medical Mistrust from Baseline to Post-Intervention: 12-item Group-Based Medical Mistrust Scale

+2 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Health Services ResearchExperimental Treatment2 Interventions

Participants watch a culturally tailored decision aid video. Surveys are completed before and after the video.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Fred Hutchinson Cancer CenterLead Sponsor

557 Previous Clinical Trials

1,343,415 Total Patients Enrolled

Vida HendersonPrincipal InvestigatorFred Hutch/University of Washington Cancer Consortium

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available positions for patients in this ongoing clinical trial?

"According to the information available on clinicaltrials.gov, this particular trial is not currently accepting new participants. The initial posting of the study was made on February 1st, 2024, with the most recent update occurring on January 12th, 2024. It's important to note that although this specific trial is closed for recruitment at present, there are a total of 519 other studies actively seeking eligible individuals to participate in their respective trials."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Expanding Clinical Trial Awareness Among Black Communities Through Digital Engagement

2024. "Expanding Clinical Trial Awareness Among Black Communities Through Digital Engagement". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06218615.

All > Paid Studies Seattle